User menu

Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions

Bibliographic reference Hammerstingl, Renate ; Huppertz, Alexander ; Breuer, Josy ; Balzer, Thomas ; Blakeborough, Anthony ; et. al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. In: European Radiology : journal of the European Congress of Radiology, Vol. 18, no. 3, p. 457-467 (2008)
Permanent URL
  1. Vogl TJ, Eichler K, Straub R, Engelmann K, Zangos S, Woitaschek D, Bottger M, Mack MG (2001) Laser-induced thermotherapy of malignant liver tumors: general principals, equipment(s), procedure(s), side effects, complications and results. Eur J Ultrasound 13:117–127
  2. Lorenz M, Staib-Sebler E, Hochmuth K, Heinrich S, Gog C, Vetter G, Encke A, Muller HH (2000) Surgical resection of liver metastases of colorectal carcinoma: short and long-term results. Semin Oncol 27(Suppl 10):112–119
  3. Lindberg CG, Lundstedt C, Stridbeck H, Traberg KH (1993) Accuracy of CT arterial portography of the liver compared with findings at laparotomy. Acta Radiol 34:139–142
  4. Heiken J P, Weyman P J, Lee J K, Balfe D M, Picus D, Brunt E M, Flye M W, Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging., 10.1148/radiology.171.1.2538862
  5. Soyer P, Bluemke D A, Hruban R H, Sitzmann J V, Fishman E K, Hepatic metastases from colorectal cancer: detection and false-positive findings with helical CT during arterial portography., 10.1148/radiology.193.1.8090923
  6. Paulson E K, Baker M E, Hilleren D J, Jones W P, Knelson M H, Nadel S N, Leder R A, Meyers W C, CT arterial portography: causes of technical failure and variable liver enhancement., 10.2214/ajr.159.4.1326885
  7. Kuszyk B S, Bluemke D A, Urban B A, Choti M A, Hruban R H, Sitzmann J V, Fishman E K, Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings., 10.2214/ajr.166.1.8571914
  8. Bonaldi V M, Bret P M, Reinhold C, Atri M, Helical CT of the liver: value of an early hepatic arterial phase., 10.1148/radiology.197.2.7480677
  9. Hollett M D, Jeffrey R B, Nino-Murcia M, Jorgensen M J, Harris D P, Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms., 10.2214/ajr.164.4.7726040
  10. Van Hoe L, Baert A L, Gryspeerdt S, Vandenbosh G, Nevens F, Van Steenbergen W, Marchal G, Dual-phase helical CT of the liver: value of an early-phase acquisition in the differential diagnosis of noncystic focal lesions., 10.2214/ajr.168.5.9129409
  11. Paulson E K, McDermott V G, Keogan M T, DeLong D M, Frederick M G, Nelson R C, Carcinoid metastases to the liver: role of triple-phase helical CT., 10.1148/radiology.206.1.9423664
  12. Pawluk RS, Tummala S, Brown JJ, Borrello JA (1999) A retrospective analysis of the accuracy of T2-weighted images and dynamic gadolinium-enhanced sequences in the detection and characterization of focal hepatic lesions. J Magn Reson Imaging 9:266–273
  13. Ward Janice, Naik Katherine S., Guthrie J. Ashley, Wilson Daniel, Robinson Philip J., Hepatic Lesion Detection: Comparison of MR Imaging after the Administration of Superparamagnetic Iron Oxide with Dual-Phase CT by Using Alternative-Free Response Receiver Operating Characteristic Analysis, 10.1148/radiology.210.2.r99fe05459
  14. Semelka RC, Martin DR, Balci C, Lance T (2001) Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. Magn Reson Imaging 13:397–401
  15. Petersein Jan, Spinazzi Alberto, Giovagnoni Andrea, Soyer Philippe, Terrier Francois, Lencioni Riccardo, Bartolozzi Carlo, Grazioli Luigi, Chiesa Antonio, Manfredi Riccardo, Marano Pasquale, Van Persijn van Meerten Els L., Bloem Johannes L., Petre Carina, Marchal Guy, Greco Alina, McNamara Michael T., Heuck Andreas, Reiser Maximilian, Laniado Michael, Claussen Claus, Daldrup Heike E., Rummeny Ernst, Kirchin Miles A., Pirovano Gianpaolo, Hamm Bernd, Focal Liver Lesions: Evaluation of the Efficacy of Gadobenate Dimeglumine in MR Imaging—A Multicenter Phase III Clinical Study, 10.1148/radiology.215.3.r00jn14727
  16. Ros P R, Freeny P C, Harms S E, Seltzer S E, Davis P L, Chan T W, Stillman A E, Muroff L R, Runge V M, Nissenbaum M A, Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions., 10.1148/radiology.196.2.7617864
  17. Torres CG, Lundby B, Tufte Sterud A, McGill S, Gordon PB, Bjerknes HS (1997) MnDPDP for MR imaging of the liver: results from the European phase III studies. Acta Radiol 38:631–637
  18. Vogl T J, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, Schwarz W, Müller P K, Bechstein W O, Mack M G, Söllner O, Felix R, Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA., 10.1148/radiology.200.1.8657946
  19. Reimer P, Rummeny E J, Shamsi K, Balzer T, Daldrup H E, Tombach B, Hesse T, Berns T, Peters P E, Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence., 10.1148/radiology.199.1.8633143
  20. Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H, Vogler H, Frenzel T, Gries H (1991) A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med 22:233–237
  21. Schuhmann-Giampieri G, Schmitt-Willich H, Press W R, Negishi C, Weinmann H J, Speck U, Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system., 10.1148/radiology.183.1.1549695
  22. Le Foie CC (1957) Etudes anatomiques et chirurgicales. Masson, Paris
  23. Rao JNK, Scott AJ (1992) A simple method for analysis of clustered binary data. Biometrics 48:577–585
  24. Obuchowski NA (1998) On the comparison of correlated proportions for clustered data. Statist Med 17:1495–1507
  25. Karhunen PJ (1986) Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 39:183–188
  26. Miller F H, Butler R S, Hoff F L, Fitzgerald S W, Nemcek A A, Gore R M, Using triphasic helical CT to detect focal hepatic lesions in patients with neoplasms., 10.2214/ajr.171.3.9725290
  27. Valls Carlos, Andía Eduard, Sánchez Anna, Gumà Anna, Figueras Juan, Torras Jaume, Serrano Teresa, Hepatic Metastases from Colorectal Cancer: Preoperative Detection and Assessment of Resectability with Helical CT, 10.1148/radiology.218.1.r01dc1155
  28. Kamel IR, Choti MA, Horton KM et al (2003) Surgically staged focal liver lesions: accuracy and reproducibility of dual-phase helical CT for detection and characterization. Radiology 227:752–757
  29. Kane RA, Hughes LA, Cua EJ, Steele GD, Jenkins RL, Cady B (1994) The impact of intraoperative ultrasonography on surgery for liver neoplasms. J Ultrasound Med 13:1–6
  30. Boutkan H, Luth W, Meyer S, Cuesta M, van Heuzen E, Prevoo W (1992) The impact of intraoperative ultrasonography of the liver on the surgical strategy of patients with gastrointestinal malignancies and hepatic metastases. Eur J Surg Oncol 18:342–346
  31. Schmidt J, Strotzer M, Fraunhofer S, Boedeker H, Zirngibl H (2000) Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: lesion-by-lesion analysis. World J Surg 24:43–47
  32. Weg N, Scheer M R, Gabor M P, Liver lesions: improved detection with dual-detector-array CT and routine 2.5-mm thin collimation., 10.1148/radiology.209.2.9807568
  33. Haider MA, Amitai MM, Rappaport DC, O’Malley ME, Hanbidge AE (2002) Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimation better? Radiology 225:137–142
  34. Kawata Shuji, Murakami Takamichi, Kim Tonsok, Hori Masatoshi, Federle Michael P., Kumano Seishi, Sugihara Eiji, Makino Shigeru, Nakamura Hironobu, Kudo Masayuki, Multidetector CT:Diagnostic Impact of Slice Thickness on Detection of Hypervascular Hepatocellular Carcinoma, 10.2214/ajr.179.1.1790061
  35. Bloed W, Van Leeuwen MS, Borel Rinkes IH (2000) Role of intraoperative ultrasound of the liver with improved preoperative hepatic imaging. Eur J Surg 166:691–695
  36. Semelka Richard C., Helmberger Thomas K. G., Contrast Agents for MR Imaging of the Liver, 10.1148/radiology.218.1.r01ja2427
  37. Ito K, Mitchell DG, Matsunaga N (1999) MR imaging of the liver: techniques and clinical applications. Eur J Radiol 32:2–14
  38. Reimer P, Rummeny EJ, Daldrup HE, Hesse T, Balzer T, Tombach B, Peters PE (1997) Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 7:275–280
  39. Stern W, Schick F, Kopp AF, Reimer P, Shamsi K, Clausen CD, Laniado M (2000) Dynamic MR imaging of liver metastases with Gd-EOB-DTPA. Acta Radiologica 41:255–262
  40. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J, Helmberger TK, Reiser MF (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 234:468–478
  41. Saito K, Kotake F, Ito N, Ozuki T, Mikami R, Abe K, Shimazaki Y (2005) Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci 4:1–9
  42. Huppertz A, Balzer T, Blakeborough A et al (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230:266–275
  43. Bellin MF, Webb JA, Van Der Molen AJ, Thomsen HS, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2005) Safety of MR liver specific contrast media. Eur Radiol 15:1607–1614
  44. Kim YK, Lee JM, Kim CS, Chung GH, Kim CY, Kim IH (2005) Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol 15:220–228
  45. Winterer JT, Kotter E, Ghanem N, Langer M (2006) Detection and characterization of benign focal liver lesions with multislice CT. Eur Radiol 16:2427–2443
  46. Lencioni R (2006) Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) guidelines on the use of contrast agents in liver ultrasound. Eur Radiol 16:1610–1613
  47. Simon G, Link TM, Wortler K, Doebereiner F, Schulte-Frohlinde E, Daldrup-Link H, Settles M, Rummeny EJ (2005) Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging. Eur Radiol 15:895–903
  48. Bartolotta TV, Midiri M, Quaia E, Bertolotto M, Galia M, Cademartiri F, Lagalla R, Cardinale AE (2005) Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol 15:1643–1649